Testing semaglutide for chronic low back pain
Treatments studied
Part of Hormones & metabolism, Pain clinical trials.
This study tests whether the drug semaglutide (a once-weekly injection used for weight loss and diabetes) can help reduce low back pain in people who are overweight or have obesity. The goal is to see if weight loss from the medication may ease back pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic low back pain (at least 4 out of 10 severity) for 3 months or longer.
- Your body mass index (BMI) is between 30 and 49.
- You are between 18 and 85 years old.
- You do not have diabetes requiring medication (other than metformin) or uncontrolled high blood pressure.
- You have not taken a GLP-1 medication (like Ozempic or Wegovy) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study checks whether semaglutide is safe and feasible for people with advanced lung diseases and higher body weight. It may help by testing a structured treatment approach, but it includes several health and safety limits.
Hear when a new Lower Back Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.